Vouliez-vous dire
risk

Résultats de la recherche - 34 results

Belgian recommendations for analytical verification and validation of immunohistochemical tests in laboratories of anatomic pathology

performance characteristics to be evaluated, (iii) the objective acceptance criteria, (iv) the evaluation method for the obtained results and (v) how and when to revalidate. A literature study and a risk ...

Pyrogen testing of phage therapeutic products

is pivotal to limit the risk of non-endotoxin contamination. These pyrogens can be detected by the monocyte activation test (MAT), which employs human blood cells to quantify pyrogenicity in vitro. In ...

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.

protection, infections occurring before 2021 remained associated with significant risk reduction against symptomatic infection. Vaccination and prior infection outperformed vaccination or prior infection ...

Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium

the study population. An adjusted logistic model was build and g-computation was executed to estimate counterfactual risks of different clinical severity outcomes (intensive care unit (ICU) transfer, ...

Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.

on the risk of COVID-19 hospitalisation. We analysed aggregated data from 27,608 COVID-19 patients hospitalised between October 2021 and February 2022, stratified by age category and vaccination ...

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.

a re-assessment. METHODS: We estimated VE against transmission of infection (VET) from Belgian contact tracing data for high-risk exposure contacts between 26/0½021 and 14/12/2021 by susceptibility (VE s) and ...

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.

Wyndham-Thomas; Lucy Catteau Source: Viruses, Volume 14, Issue 4 (2022) Keywords: Ad26COVS1 Adult Belgium BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans incidence Prospective Studies Risk Factors SARS-CoV-2 ...

Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium

Publication Type: Scientific poster, presentation or proceeding Authors: Veerle Stouten; Pierre Hubin; Freek Haarhuis; Joris Van Loenhout; Matthieu Billuart; Ruben Brondeel; Toon Braeye; Herman Van Oyen; Chloé Wyndham-Thomas; Lucy Catteau Source: (2022) H ...

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.

Goriely; Maria Goossens; Ariën, Kevin K; I Desombere; Arnaud Marchant Source: Clin Infect Dis (2021) Abstract: BACKGROUND: Residents of nursing homes (NH) are at high risk of COVID-19 related morbidity and ...

Identification of flavouring substances of genotoxic concern present in e-cigarette refills

compounds in e-liquids, flavourings of genotoxic concern are present and might pose a health risk for e-cigarette users. Health Topics:  Effectiveness and safety of vaccines, medicines and health products- ...

QR code

QR code for this page URL